Marrero RMT

Idioma: Español
Referencias bibliográficas: 21
Paginas:
Archivo PDF: 192.50 Kb.

RESUMEN

Las enfermedades tiroideas son un importante problema de salud que afecta a un gran porcentaje de la población. Las pruebas bioquímicas constituyen el pilar fundamental para su diagnóstico y seguimiento. El desarrollo de ensayos de segunda y tercera generación ha supuesto un gran avance en el diagnóstico de estas enfermedades. El texto incluye los ensayos utilizados para diagnosticar y tratar las diferentes enfermedades tiroideas, provee información bioquímica y clínica actualizada contenida en secciones referidas a la utilidad clínica de las determinaciones de hormonas tiroideas totales y libres, anticuerpos antitiroideos, tirotropina humana y tiroglobulina, de manera que pueda ofrecer, tanto al laboratorio como al médico, un panorama general de la utilidad y la capacidad actual de estas pruebas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Drinka PJ, Siebers M, Voeks SK. Poor positive predictive value of low sensitive thyrotropin assay levels for hyperthyroidism in nursing home residents. South Med J. 1993;86:1004-7.

2. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Rodgers H, et al. The incidence of thyroid disorders in the community; a twenty year follow up of the Whickham survey. Clin Endocrinol. 1995;43:55-68.

3. Fish LH, Schwarz HL, Cavanaugh MD, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism and bioavailability of levothyroxine in the treatment of hypothyroidism. N Engl J Med. 1987;316:764-70.

4. Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity and thyroid function in patients with sporadic nontoxic goiter. Am J Med. 1990;89:602-8.

5. Talbot JA, Lambert A, Anobile CJ, McLoughlin JD, Price A, Weetman AP, et al. The nature of human chorionic gonadotrophin glycoforms in gestational thyrotoxicosis. Clin Endocrinol. 2000;55:33-9.

6. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the Thyroid. Endocrinol Rev. 2001;22:240-54.

7. Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clin Chem. 1996;42:188-92,103.

8. Hamblin PS, Dyer SA, Mohr VS, Le Grand BA, Lim C-F, Tuxen DB, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab. 1986;62:717-22.

9. La Franchi SH, Snyder DB, Sesser DE, Skeels MR, Singh N, Brent GA. Follow-up of newborns with elevated screening T4 concentrations. J Pediatr. 2003;143:296-301.

10. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab. 2007 Jun;21(2):277-305.

11. Refetoff S. Resistance to Thyroid Hormone. In: Braverman LE and Utiger RD, editor. The Thyroid. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 1028-43.

12. Feldt-Rasmussen U. Anti-thyroid peroxidase antibodies in thyroid disorders and non thyroid autoimmune diseases. Autoimmunity. 1991;9:245-5.

13. Stockigt JR. Free thyroid hormone measurement: a critical appraisal. Endocrinol Metab Clin N Am. 2001;30:265-89.

14. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005;90:5489-96.

15. Ward DL, Bing-You RG. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations. Endocrinol Pract. 2001;7:52-8.

16. Spencer CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab. 2004;89:3702-4.

17. Galofré JC. Management of subclinical hyperthyroidism. Rev Med Univ Navarra. 2007;51:18-22.

18. Ericsson UB, Tegler L, Lennquist S, Christensen SB, Stahl E, Thorell JI. Serum thyroglobulin in differentiated thyroid carcinoma. Acta Chir Scand. 1984;150:367-75.

19. Wallaschofski H, Kuwert T, Lohmann T. TSH-receptor autoantibodies-differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Exp Clin Endocrinol Diabetes. 2004;112(4):171-4.

20. Feldt-Rasmussen U, Petersen PH, Date J, Madsen CM. Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter. J Endocrinol Invest. 1982;5:161-4.

21. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab. 1999;84:3877-85.